Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of MOR106 Administered Concomitantly With Topical Corticosteroids, in Adult Participants With Moderate to Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating MOR106 with topical corticosteroids in adults with moderate to severe atopic dermatitis was terminated; results were posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• MOR106

Snippet

Sponsor: Galapagos NV | Conditions: Atopic Dermatitis | Phase 2 | Status: TERMINATED | Results posted: 2021-01-05